A First For England's NICE - Interim Review Of Spinraza Access Agreement Gets Under Way

Review Will Determine Whether Access To Biogen's SMA Treatment Will Be Expanded

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".